Actavis
Fosaprepitant
Manufacturer:
Actavis
Name:
Fosaprepitant
HCPCS Code Descriptor:
Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
Category:
J Code
HCPCS:
J1456
NDC(s):
00591-4385-79,
Primary Type:
Oncology-Anti-Emetic
Route of Administration:
Intravenous
About:
Fosaprepitant is an Oncology-Anti-Emetic drug manufactured by Actavis and administered via the Intravenous route of administration. The J Code: J1456 is aligned to the drug Fosaprepitant.